cGMP Recombinant Human Interleukin-12, rHu IL-12

cGMP Recombinant Human Interleukin-12, rHu IL-12

Log in for price

Interleukin-12 (IL-12) was identified as a factor secreted by human Epstein-Barr (EBV)-transformed B cell lines. IL-12 is produced predominantly by monocytes and NK cells. Human IL-12 is not active on mouse cells, but murine IL-12 is active on both murine and human lymphocytes.

Features and Specifications:

  • Lyophilized 
  • Pharmaceutical grade
  • Sterile-filled
  • Customization available under contract:
    • Liquid formulations
    • Aliquot sizing and packaging
    • Tailored biological activity assays

Quality Statement

Akron’s cGMP Cytokines are manufactured, tested and released in compliance with relevant cGMP guidelines. USP Chapter ‹1043› “Ancillary materials for cell, gene and tissue-engineered products” has been followed in the design of these products.

For more information and to purchase products, please login.

The biological activity of recombinant human IL-12 was measured by its ability to stimulate the proliferation of PHA-activated human T lymphoblasts. IL-12 has anti-angiogenic properties. Recombinant Human Interleukin-12 is a glycosylated disulfide linked heterodimeric polypeptide that contains 503 amino acids and has a molecular weight of 75 kDa. It is comprised of disulfide-bonded 35 kDa (p35) and 40 kDa (p40) subunits. rHu IL-12 is purified by proprietary chromatographic techniques.